Login
Products
Login
Home
Alerts
Search
Watchlists
Products

Mold-Tek Packaging Ltd

MOLDTKPAC
NSE
546.10
1.52%
Last Updated:
09 Apr '26, 3:59 PM
Company Overview
Alert
Watchlist
Note

Mold-Tek Packaging Ltd

MOLDTKPAC
NSE
546.10
1.52%
09 Apr '26, 3:59 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
1,815Cr
Close
Close Price
546.10
Industry
Industry
Packaging - FMCG/Consumers
PE
Price To Earnings
26.48
PS
Price To Sales
2.13
Revenue
Revenue
851Cr
Rev Gr TTM
Revenue Growth TTM
12.68%
PAT Gr TTM
PAT Growth TTM
10.04%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
185186170165177197191191203241210198
Growth YoY
Revenue Growth YoY%
3.8-10.6-6.76.9-4.25.812.315.314.622.39.74.1
Expenses
ExpensesCr
149151138135141161158157164194171160
Operating Profit
Operating ProfitCr
363532303636343438473938
OPM
OPM%
19.318.918.918.320.118.217.617.718.919.418.619.4
Other Income
Other IncomeCr
111001101100
Interest Expense
Interest ExpenseCr
122223434444
Depreciation
DepreciationCr
891091012121213141415
PBT
PBTCr
272521192422191822302119
Tax
TaxCr
466566556855
PAT
PATCr
231916141817141416221514
Growth YoY
PAT Growth YoY%
32.8-13.7-19.2-12.9-21.9-11.8-10.1-3.9-9.535.59.75.2
NPM
NPM%
12.410.19.28.610.28.47.47.28.09.37.47.2
EPS
EPS
6.95.74.74.35.45.04.34.14.96.74.74.3

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
285276301339394437479631730699781851
Growth
Revenue Growth%
12.3-3.39.112.816.111.09.531.915.6-4.311.89.0
Expenses
ExpensesCr
245230249276322357383511594565640689
Operating Profit
Operating ProfitCr
40465263728096121135133142163
OPM
OPM%
14.016.617.318.718.318.320.019.118.619.118.119.1
Other Income
Other IncomeCr
1121-10-2021123
Interest Expense
Interest ExpenseCr
7124710109471417
Depreciation
DepreciationCr
8910121519212630394957
PBT
PBTCr
2537414940496487103898192
Tax
TaxCr
81314171611162322222124
PAT
PATCr
172427322438486480676169
Growth
PAT Growth%
86.042.911.617.9-23.958.425.932.426.4-17.2-9.113.1
NPM
NPM%
5.98.78.99.36.18.710.010.111.09.57.88.1
EPS
EPS
6.08.69.711.48.613.116.922.124.420.118.220.6

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
141414141414141617171717
Reserves
ReservesCr
102115142167177183227423542578621652
Current Liabilities
Current LiabilitiesCr
3761681071231261487399143189229
Non Current Liabilities
Non Current LiabilitiesCr
17141215304032443882110121
Total Liabilities
Total LiabilitiesCr
1692042363023433634365746968209371,019
Current Assets
Current AssetsCr
88106107145128128170271239274302342
Non Current Assets
Non Current AssetsCr
8298129157215235266303456546635677
Total Assets
Total AssetsCr
1692042363023433634365746968209371,019

Cash Flow

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
3238269714761315279110
Investing Cash Flow
Investing Cash FlowCr
-9-24-25-40-66-30-51-55-141-143-136
Financing Cash Flow
Financing Cash FlowCr
-23-14-131-6-17-1056-105925
Net Cash Flow
Net Cash FlowCr
000000041-50
Free Cash Flow
Free Cash FlowCr
24207-27-1292-477-62-13
CFO To PAT
CFO To PAT%
191.8157.398.029.4295.7124.0126.04.0188.6118.4182.3
CFO To EBITDA
CFO To EBITDA%
80.982.850.814.799.159.163.12.1112.059.278.0

Ratios

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2953896418877304801,1062,2782,9972,6061,399
Price To Earnings
Price To Earnings
18.717.423.928.030.312.622.835.837.339.123.1
Price To Sales
Price To Sales
1.01.42.12.61.91.12.33.64.13.71.8
Price To Book
Price To Book
2.53.04.14.93.82.44.65.25.44.42.2
EV To EBITDA
EV To EBITDA
7.79.013.115.211.47.312.619.122.420.511.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
44.551.049.640.539.442.943.140.440.343.243.6
OPM
OPM%
14.016.617.318.718.318.320.019.118.619.118.1
NPM
NPM%
5.98.78.99.36.18.710.010.111.09.57.8
ROCE
ROCE%
25.024.522.420.316.819.521.219.917.613.311.7
ROE
ROE%
14.618.717.317.512.719.420.014.514.411.29.5
ROA
ROA%
10.011.811.410.57.010.511.011.111.68.16.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Overview** Mold-Tek Packaging Limited, established in 1985 and listed in 1993, is India’s leading manufacturer of rigid plastic packaging containers. The company is recognized as the first Indian firm to introduce **In-Mold Labeling (IML)** technology with robotic automation, and it remains the only global packaging company that **in-house designs and manufactures its own IML robots and produces IML labels**. Over 39 years, Mold-Tek has built a vertically integrated, innovation-driven business model focused on high-quality, hygienic, and customized packaging across diverse industries. --- ### **Core Strengths & Competitive Advantages** 1. **End-to-End Vertical Integration** Mold-Tek controls every stage of the packaging value chain—from design and mold manufacturing to production and delivery. This full backward integration includes: - In-house **tool room** equipped with 3-axis and 5-axis CNC machines - **Robotics and automation** for IML and production - **IML label production**, heat transfer labeling (HTL), and advanced printing capabilities - Centralized **design studio (D3: Design, Develop, Deliver)** with 200+ concepts developed and 3 India Star Awards won 2. **Speed and Customization** The in-house tool room enables rapid product development—**custom pharma packaging in weeks vs. industry averages of 2–3 months**—giving Mold-Tek a decisive edge in serving clients with time-sensitive or regulated packaging needs. 3. **Technology & Innovation** - Pioneered **laser-marked, single-piece desiccant canisters** and **IML-equipped EV tubes** - Developed **digital IML with dual QR codes** (visible for engagement, hidden for authentication) - Implements **100% camera-based inspection systems** for pharma-grade quality --- ### **Business Segments & Product Portfolio** Mold-Tek serves multiple B2B sectors, including: - **Pharmaceuticals** (tablets, EV tubes, canisters, CRC/CT closures) - **Electric Vehicles (EV)** – nutraceuticals, batteries, motors - **Food, FMCG, and Retail** – edible oil, protein powders, ready-to-eat, ice cream, restaurant packs - **Paints, Lubricants, and Chemicals** - **Pumps and Dispensers** – twist-lock, sprayers Key products: - **Q-Packs** (1–20L for cashew, oil, detergents) - **Effervescent Tubes & Canisters** with IML - **IML, HTL, DOP, Screen Printed Containers** - **Pumps** for hygiene, personal care - **Custom containers** for cosmetics, dairy, agri-products --- ### **Strategic Growth Drivers (Nov 2025 Update)** #### 1. **Electric Vehicle (EV) Packaging – High-Growth Engine** - EV-related products—**tubes, caps, and bottles**—are key growth drivers. - Two major EV customers are expected to generate **₹10+ crore each in annual revenue**, starting from **₹70–80 lakhs per quarter**, scaling to **₹2–3 crore per quarter by Q4 FY26**. - Over **50 customer visits** with **20–25 clients already in production**, no single client exceeds 10% of sales. - Works with **4 of India’s top 5 EV segment CMOs**, with canister orders beginning to scale. #### 2. **Pharmaceutical Packaging – Rapid Expansion & High Margins** - The pharma division has **breakeven within its first year**, a significant achievement versus the 3-year industry norm. - Revenue rose to **₹6.67 crore in Q4 FY25**, contributing to ~₹30 crore in full-year FY26 guidance and **projected to exceed ₹50 crore by FY27**. - Achieved **over 20 client audits**, with **2–3 commercial clients** driving volume growth and **15+ more in pipeline**. - Secured **US-DMF, Health Canada, and ISO 8 cleanroom certifications**; new Sultanpur plant is **Type III US-DMF accredited**. - Products include **IML-decorated effervescent tubes, child-resistant 'Squeeze & Lock' caps, and laser-engraved canisters**. - **Export potential**: First commercial supply to U.S.; pursuing Europe (Germany in stability testing); targeting import substitution and Bangladesh exports. #### 3. **Capacity & Infrastructure Expansion** - Total installed capacity: **55,000 metric tons per annum (TPA)** across **13 manufacturing facilities**. - **ABG (automotive/industrial) capacity** stands at **10,000 tons** across 3 plants; **60–65% full-year utilization projected**, up from 2,900 tons in H1. - **Panipat Plant Expansion**: - Current capacity: **5,000 tons**, expanding to **6,500–7,000 tons** - Adding **1,000 tons for Food & FMCG**, **700–800 tons for pails** - **CapEx Guidance**: **₹70–80 crore for FY26**, including: - **₹25 crore** for pharma expansion - **₹14–15 crore** for Mahad plant - **₹7–8 crore** for printing - Land acquired in **Sultanpur** for brownfield pharma expansion; major investments from **FY27** #### 4. **New Facility & Product Pipeline** - **New pharma facility** on recently acquired **Sultanpur land**—construction starts **Dec–Jan 2025–26**, **operational by H2 FY26**. - 2025 commissioning of **state-of-the-art pharma plant** in Sultanpur with: - Class 100k cleanrooms - ISO 8 certification - US-DMF and Health Canada compliance - **Pump Segment**: - Generates **₹30–40 lakhs/month** from pharma and cosmetics - Minimal U.S. exposure (**₹2–3 crores/year**), unaffected by tariffs #### 5. **Cost & Operational Improvements** - Integration of **IML + in-house HTL label manufacturing** at Sultanpur will reduce **consumable costs by ₹1/kg (~7–10%)**. - Benefits expected from **Q3–Q4 FY26**. - Deployment of **automated systems, 100% camera inspections**, and **digital printing** for fast turnaround. --- ### **Recent Performance & Outlook** - **FY25 Revenue Growth**: **17.34%**, driven by detergent and cashew packaging - **Food & FMCG Segment**: Grew **11.76%**, supported by new beverage and nutritional packs - **Restaurant Packs**: **140% YoY growth** (launched 2023–24) - **Key Clients Added (2025)**: Marico, ID Fresh, Mankind, Inventia, Laurus, Amnlife, Pulse Pharma - **Export Growth**: **55% increase in thinwall**, **doubled in first 9 months FY25**—driven by lubricant pails, pharma EV tubes, and U.S. canister orders --- ### **Leadership & Strategic Oversight** - **Mr. J. Rana Pratap**, SVP – Corporate: Leads strategy, pharma packaging (effervescent tubes, bottles, canisters), and top strategic accounts. IIT Delhi + IIM Lucknow, with 13+ years at Mold-Tek. - **Mr. A. Durga Sundeep**, SVP – Operations & Finance: Oversees planning across **16 facilities**, 2,000+ SKUs, digital systems for forecasting, costing, and margin analysis. - **Mr. Subramanyam Adivishnu**, Promoter: Oversees **in-house tool room and R&D**; pioneered IML and robotics in India.